2019
DOI: 10.1016/j.ejmech.2019.03.024
|View full text |Cite
|
Sign up to set email alerts
|

Multi-target compounds acting in cancer progression: Focus on thiosemicarbazone, thiazole and thiazolidinone analogues

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
45
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 109 publications
(47 citation statements)
references
References 85 publications
0
45
0
Order By: Relevance
“…Thiosemicarbazones (TSCs) and their metal complexes are versatile molecules with a wide spectrum of antimicrobial, antitrypanosomal, antitumor, antimalarial, and antiviral activities and have been studied intensely in pharmaceutical and medicinal chemistry [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 ]. TSCs are able to block the genetic expression of wide variety of viruses [ 11 , 13 ], including the herpes simplex virus [ 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 ].…”
Section: Introductionmentioning
confidence: 99%
“…Thiosemicarbazones (TSCs) and their metal complexes are versatile molecules with a wide spectrum of antimicrobial, antitrypanosomal, antitumor, antimalarial, and antiviral activities and have been studied intensely in pharmaceutical and medicinal chemistry [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 ]. TSCs are able to block the genetic expression of wide variety of viruses [ 11 , 13 ], including the herpes simplex virus [ 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 ].…”
Section: Introductionmentioning
confidence: 99%
“…All samples for NMR measurements were prepared by dissolving the compounds in [D 6 ]DMSO. 1 H, 13 C, COSY, HSQC, HMBC NMR spectra were acquired on a Bruker Avance III 500 MHz FT NMR spectrometer at NMR spectrometry Centre of the Faculty of Chemistry of the University of Vienna. 1 H and 13 C NMR shifts were referred relative to residual solvent signal.…”
Section: Chemicalsmentioning
confidence: 99%
“…The first compound was tested in vivo in the 1950s, attracting the interest of researchers [1]. Since then, a large number of TSCs with antiproliferative activity has been reported, but only some of them reached clinical trials [2].The academic interest in TSCs has been recently rekindled, when two new compounds, namely COTI-2 ((E)-N -(5,6,7,8-tetrahydroquinolin-8-ylidene)-4-(pyridine-2-yl)piperazine-1-carbothiohydrazide) and DpC (di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone), entered phase I clinical trials for the treatment of gynaecological malignancies, colorectal, lung, pancreatic cancer and advanced (or resistant) tumours [3,4].TSCs and their metal complexes are intracellularly reactive agents with multi-target features [5][6][7][8][9][10][11][12][13][14], which often exhibit marked cytotoxic effects both in vitro and in vivo, as described elsewhere [1,2,15,16]. The aromatic moiety and metal-binding domain are the basic structural requisites for their pharmacological activity.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…This has led the high demand for novel drugs with enhanced, targeted activity. Thiosemicarbazones (TSC) are very promising molecules having interesting pharmacological properties with remarkable antioxidant, antiviral, antibacterial, anticancer, antitumor, antimalarial, ribonucleotide reductase enzyme inhibition, and antifungal activities when coordinated to metals but also in their absence 1‐7 . TSC are synthesized through condensation of thiosemicarbazides with aldehydes or ketones 1‐3 .…”
Section: Introductionmentioning
confidence: 99%